The use of a spacer in the delivery of large (Fluticasone Propionate) and small particle (Qvar®) inhaled corticosteroid (ICS) in asthma (FP and Qvar Spacer vs Non-Spacer in Asthma)

Study identification

• PURI:
  https://redirect.ema.europa.eu/resource/27687
• EU PAS number:
  EUPAS7744
• Study ID:
  27687
• Official title and acronym:
  The use of a spacer in the delivery of large (Fluticasone Propionate) and small particle (Qvar®) inhaled corticosteroid (ICS) in asthma (FP and Qvar Spacer vs Non-Spacer in Asthma)
• DARWIN EU® study:
  No
• Study countries:
  United Kingdom
• Study description:
  The objective of this study is to investigate the real life effectiveness of ICS delivery of Fluticasone Propionate (FP) and Qvar® (beclomethasone dipropionate HFA) by pMDI with spacer compared to pMDI alone.
• Study status:
  Ongoing

Research institutions and networks

Institutions

Observational & Pragmatic Research Institute Pte (OPRI)

United Kingdom

Study timelines

Date when funding contract was signed

Planned: 01/03/2014

Actual: 01/03/2014

Study start date

Planned: 01/04/2014

Actual: 01/04/2014

Date of final study report

Planned: 15/12/2014

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

TEVA

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable